GlobalView

Showing items 1 - 3 of 3.

Add to Quick Collection   All 3 Results

  • First
  • Previous
  • 1
  • Next
  • Last
Sort:
  Add All Items to Quick Collection
Add  The hydroxyl epimer of doxorubicin controls the rate of formation of cytotoxic anthracycline-DNA adducts
Authors: Forrest, Robert A. | Swift, Lonnie P. | Evison, Benny J. | Rephaeli, Ada. | Nudelman, Abraham. | Phillips, Don R. | Cutts, Suzanne.
Date: 2013
Subject: 060199 Biochemistry and Cell Biology not elsewhere classified | 111205 Chemotherapy
Language: en
Type: journal article
Identifier: http://hdl.handle.net/1959.9/497501
Description: First published online 2012.
Add  M2, a novel anthracenedione, elicits a potent DNA damage response that can be subverted through checkpoint kinase inhibition to generate mitotic catastrophe.
Authors: Evison, Benny J. | Pastuovic, Mile. | Bilardi, Rebecca A. | Forrest, Robert A. | Pumuye, Paul P. | Sleebs, Brad E. | Watson, Keith G. | Phillips, Don R. | Cutts, Suzanne.
Date: 2011
Subject: 060199 Biochemistry and Cell Biology not elsewhere classified | 110105 Medical Biochemistry: Nucleic Acids | 111205 Chemotherapy
Language: en
Type: journal article
Identifier: http://hdl.handle.net/1959.9/536505
Description: Funding Information Note: Funded by the Australian National Health and Medical research Council (grant 487333).
Add  Activation of clinically used anthracyclines by the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate.
Authors: Cutts, Suzanne M. | Swift, Lonnie P. | Pillay, Vinochani. | Forrest, Robert A. | Nudelman, Abraham. | Rephaeli, Ada. | Phillips, Don R.
Date: 2007.
Subject: 111200 Oncology and Carcinogenesis | 1112 (four-digit-FOR)
Language: en
Type: journal article
Identifier: http://hdl.handle.net/1959.9/462499
Description: DEST collection year : 2008
  • First
  • Previous
  • 1
  • Next
  • Last